Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bausch & Lomb to Report 2005 Third-Quarter Results Wednesday, October 26, 2005.


ROCHESTER, N.Y. -- Bausch & Lomb (NYSE NYSE

See: New York Stock Exchange
: BOL BOL Bolivia (ISO Country code)
BOL Books Online
BOL Bole (SIL code, Nigeria)
BOL Bill Of Lading
BOL Beginning Of Line
BOL Best Of Luck
BOL Buzz Out Loud
BOL Bruin Online
BOL Beginning Of Life
) will report its 2005 third-quarter results on Wednesday, October 26. On that day, the Company will issue a news release over Business Wire by 8:00 a.m. Eastern time. The news release also will be posted on the Company's web site: www.Bausch.com.

Also on October 26, the Company will hold a conference call for investors at 10:00 a.m. (ET) to discuss the results. Members of the news media are invited to listen to the call.

The conference call can be accessed on October 26 in three ways:

--By telephone - call 913-981-5507 between 9:50 a.m. and 10:00 a.m.;

--By internet - log on to www.vcall.com;

--By internet - log on to the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 page of the Company's Web site www.bausch.com.

The conference call will be available by telephone rebroadcast beginning at 1:30 p.m. (ET) on October 26, through midnight, Sunday, October 30. The call-in number to listen to the replay is 719-457-0820; the confirmation code is 814967.

All 2005 earnings release dates are listed on the Investor Relations page, financial information section on our Web site, www.bausch.com.

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable gas permeable gas adj (lenses) → luftdurchlässig  contact lenses contact lenses contact nplverres mpl de contact

contact lenses contact nplKontaktlinsen pl

contact lenses npl
 and lens care products, and ophthalmic ophthalmic /oph·thal·mic/ (of-thal´mik) ocular (1).

oph·thal·mic
adj.
Of or relating to the eye; ocular.


Ophthalmic
Pertaining to the eye.
 surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York This article is about the city of Rochester in Monroe County. For the town in Ulster County, see Rochester, Ulster County, New York.
Rochester, once known as The Flour City, and more recently as The Flower City or
. Bausch & Lomb's 2004 revenues were $2.2 billion; it employs approximately 12,400 people worldwide and its products are available in more than 100 countries. More information about the Company can be found on the Bausch & Lomb Web site at www.bausch.com. Copyright Bausch & Lomb Incorporated.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 11, 2005
Words:315
Previous Article:Schaeffer's Midday Options Update Features Sprint Nextel Corp., Alcoa, Genentech, Time Warner, and RealNetworks.
Next Article:Major New Study to Be Released on Health Status and Trends of Mexican Workers Living in United States.
Topics:



Related Articles
Bausch & Lomb Schedules Third-Quarter Earnings Call on Wednesday, October 20, 2004.
Bausch & Lomb Reports Solid First Quarter.
Bausch & Lomb Announces Triggering Event for Conversion of $4.1 Million of 2003 Convertible Senior Notes Due 2023 and $155.9 Million of 2004 Senior...
Bausch & Lomb Reassesses PureVision -TM- Toric Lens U.S. Launch Plan Due to Overwhelming Demand for Its Silicone Hydrogel Lenses.
Bausch & Lomb to Report 2005 Second-Quarter Results Wednesday, July 27, 2005.
Bausch & Lomb to Acquire China's Leading Ophthalmic Pharmaceuticals Company.
Bausch & Lomb Will Delay Filing its Quarterly Report on Form 10-Q for the Third Quarter and Nine Months Ended September 24, 2005.
Bausch & Lomb Provides Information Regarding U.S. Sales of ReNu(R) with MoistureLoc(R) Solution.
Bausch & Lomb Asks Retailers to Remove U.S.-Manufactured ReNu(R) with MoistureLoc(R) from Shelves; and Recommends Consumers Switch to Another...
Lawyers focus on lens solution lawsuits.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles